TANG CAPITAL MANAGEMENT LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
TANG CAPITAL MANAGEMENT LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,073,500
-84.8%
150,000
-88.2%
0.43%
-82.5%
Q3 2022$20,204,000
+16.0%
1,265,9000.0%2.48%
-6.2%
Q2 2022$17,419,000
-13.2%
1,265,9000.0%2.64%
-34.2%
Q1 2022$20,077,000
-63.7%
1,265,900
-50.0%
4.02%
-63.9%
Q4 2021$55,269,000
-27.0%
2,531,8000.0%11.12%
-29.2%
Q3 2021$75,676,000
-32.5%
2,531,8000.0%15.71%
-29.6%
Q2 2021$112,133,000
-0.2%
2,531,8000.0%22.32%
-29.4%
Q1 2021$112,336,000
-30.9%
2,531,800
-14.6%
31.61%
+27.3%
Q4 2020$162,627,000
+139.9%
2,965,4850.0%24.83%
+102.4%
Q3 2020$67,791,000
+9.2%
2,965,4850.0%12.27%
+103.3%
Q2 2020$62,068,000
+50.0%
2,965,4850.0%6.03%
+3.9%
Q1 2020$41,369,000
-38.7%
2,965,4850.0%5.81%
-28.0%
Q4 2019$67,494,000
+95.4%
2,965,4850.0%8.06%
+36.4%
Q3 2019$34,548,000
-22.3%
2,965,4850.0%5.91%
-1.7%
Q2 2019$44,482,000
-14.5%
2,965,4850.0%6.01%
-37.3%
Q1 2019$52,015,000
+18.4%
2,965,4850.0%9.58%
-4.9%
Q4 2018$43,948,000
-39.8%
2,965,4850.0%10.08%
-15.4%
Q3 2018$73,010,000
+25.4%
2,965,4850.0%11.92%
+61.6%
Q2 2018$58,212,000
+4.7%
2,965,4850.0%7.38%
-9.7%
Q1 2018$55,603,0002,965,4858.17%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders